Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta ‐analysis?

Key Points Closure of patent foramen ovale (PFO) in embolic stroke of undetermined source (ESUS) reduces recurrent stroke compared with antiplatelet therapy in select patients but increases risk of atrial fibrillation. Device closure is an attractive option for young patients with an anatomically higher risk PFO and imaging proven ESUS. Benefit of PFO closure in ESUS compared with oral anticoagulation remains undefined.

https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.27964?af=R

Source: Catheterization and Cardiovascular Interventions - November 26, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Arka Chatterjee, William B. Hillegass Tags: Valvular and Structural Heart Diseases Source Type: research